We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
We work to help our clients understand and evaluate risks and opportunities as a result of actions by Congress, the White House and executive branch agencies such as the Health and Human Services Agency, the Centers for Medicare and Medicaid Services, and the Food and Drug Administration, as well as state-level actions by legislatures, governors and state agencies.
Our Healthcare Policy team is comprised of former White House, executive branch agency, senior congressional staff and senior state Medicaid officials that combine a comprehensive understanding of the current legislative and regulatory environment with industry-leading outlook into catalysts and the key changes they drive
A private equity firm was considering an investment in a California-based provider-led managed care network that administers healthcare services through its network of medical groups, independent physician associations, urgent care facilities, and affiliated health plans.
Marwood found that the multiple potential risks facing the MA program were all unlikely to affect the Company in a negative way, mainly because slim (and waning) Democrat Congressional majorities would be effectively powerless in the short-term, with regards to MA. Marwood also determined that both MA and commercial plans viewed the Company’s delivery model positively, and that while there could be changes to the Medicaid managed care system, none would hurt the Company.